Table 1.
Study | Model | Mitochondrial Source | Protocol/Application | Outcomes |
---|---|---|---|---|
Doulamis 2020 [134] |
Diabetic and non-diabetic rats | -autologous or from diseased animals -pectoralis major muscle |
-ischemia/reperfusion in Langendorff perfused hearts in a T2D model -antegrade i.c. |
-Prior: mitochondrial ATP content ↓ in diabetic rats -LVdevP ↑ in both groups (higher in group with healthy mitochondria), LVEDP ↓ + IS ↓in both groups →no difference in cardiac function, IS and CBF between both groups (except LVdevP) -tissue ATP ↑ (higher in group with healthy mitochondria) |
rats |
-syngeneic -pectoralis major muscle |
-for biodistribution -antegrade i.c. |
-distributed throughout the heart | |
-human cardiac fibroblasts | -for biodistribution -retrograde i.c. |
-distributed within myocardial fibers | ||
Ramirez-Barbieri 2019 [132] | mice | -syngeneic + allogeneic -gastrocnemius + quadriceps femoris muscle |
-single or serial i.p. in a skin graft model |
-no inflammatory or autoimmune responses (IgM antibodies, IL4, TNF-α, skin graft survival time, lymphocyte infiltration, free mtDNA, histological changes in heart and lung) |
Moskowitzova 2019 [130] | mice | -syngeneic -gastrocnemius muscle |
-heart transplantation -29h cold ischemia time -i.c. before transplantation + 5 min after transplantation |
-beating score ↑, EF ↑and FS ↑, necrosis and inflammatory cell infiltration ↓ -no differences in TUNEL+ nuclei -myocardial injury (contraction bands) in vehicle groups |
rats | -antegrade i.c. | -diffuse distribution in the heart | ||
Guariento 2020 [125] | pigs | -autologous -pectoralis muscle |
-circulatory death/Ischemia/cardioplegia/reperfusion -single or two injections (2nd after 2 h of ex-situ heart perfusion and reperfusion for additional 2 h) |
-LV/ventricular peak developed pressure ↑, FS ↑, myocardial oxygen consumption ↑, IS ↓ |
Guariento 2020 [126] | pigs | -autologous --pectoralis major muscle |
-preischemic intracoronary single or serially injections -ischemia/reperfusion |
-CBF ↑ pre-RI period and during reperfusion -myocardial function ↑ (EF ↑ + LV Pdev ↑, LV dP/dt max↑, LV Ped ↓ SS ↑, FS ↑), IS ↓; necrosis + edema ↓, preserved mitochondrial structure → no differences between single and serial injections |
McCully 2009 [129] | rabbits | -allogenic -left ventricle |
-ischemia/reperfusion-in excised hearts | -LVPDP + SS + ATP content ↑, LVEDP + IS + CK-MB and cTnI, caspase-3-like activity ↓, -no differences in TUNEL+ nuclei -mitochondria viable and detectable; located near the myocytes |
-frozen mitochondria/ mitochondrial components or mitochondrial DNA/RNA | -LVPDP ↓, LVEDP ↑, SS ↓ + IS ↑, RCI ↓, oxygen consumption ↓ compared to fresh mitochondria | |||
Masuzawa 2013 [128] | in vivo: rabbits |
-autologous -pectoralis major muscle optical mapping: liver mitochondria |
-ischemia/reperfusion recovery for 2h or 28days |
-no arrhythmogenicity, decreased necrosis, enhanced postischemic function, IS ↓, CK-MB ↓ and cTnI ↓, increase of tissue ATP content in AAR, percent systolic wall thickening ↑ compared to vehicle, segmental hypokinesis in vehicles TUNEL+ nuclei ↓ and caspase 3 activity ↓, no inflammatory effect (hsCRP↓, IL6↓, TNFa↓), no antimitochondrial antibodies after 4 weeks -proteomic analyses: generation of precursor metabolites for energy ↑ and cellular respiration↑ -mitochondria in the interstitial spaces surrounding cardiomyocytes at 0, 2, 4, 8 and 24 h following injection-fraction of the labeled mitochondria within cardiomyocytes 2 h after injection |
-xenogeneic human mitochondria from HeLa cells |
separate group: -biodistribution -injection in tissue |
-majority of mitochondria in the interstitial spaces, partly localized within cardiomyocytes | ||
in vitro | - HeLa- derived intact and sonicated mitochondria | subgroup: -co culture of HeLa- derived intact and sonicated mitochondria and human PBMCs |
no upregulation of cytokines associated with rejection (IL-1, IL-4, IL-6, IL-12, IL-18, IP-10 and macrophage inflammatory protein-1a and -1b) EGF↑, GRO↑, IL-6↑ and MCP-3↑ →associated with enhanced postinfarct cardiac function |
|
in vitro | -syngeneic -rat liver mitochondria |
subgroup: -internalization -neonatal rat cardiomyocytes cocultured with mitochondria |
-majority of mitochondria internalized within 24 h of incubation -oxygen consumption ↑ |
|
in vitro | -xenogeneic -HeLa cell mitochondria |
subgroup: -internalization -cardiomyocytes incubated with mitochondria |
-mitochondria adherent to cells within 2 h and internalized within 8–24 h -no colocalization with lysosomes or autophagosomes |
|
Kaza 2017 [127] | pigs | -autologous -pectoralis major muscle |
-ischemia/reperfusion -subendocardial injections -4 weeks recovery |
-IS↓, no immune and inflammatory response and cytokine activation, no arrhythmia, -mitochondrial damage and contraction bands in vehicle hearts -no differences in systolic function (EF, FS and global circumferential strain) |
Blitzer 2020 [122] | pigs | -autologous -pectoralis major muscle |
-ischemia/reperfusion -delayed i.c. application |
-LVEF↑, EF ↑, FS ↑, fractional area change, IS ↓, LV EDP ↓ -maximal rate of rise of LV pressure ↑, SS↑, LVFS↑, LVFAC↑, transient CBF ↑ |
Emani 2017 [124] | children | -autologous -rectus abdominis muscle |
-epicardial injection 2–15 d after ECMO cannulation |
-4/5 improvement in ventricular function separation from ECMO, 3/5 survived -no signs of immune responses (respiratory and renal status) |
Shin 2019 [116] | pigs | -autologous -pectoralis major muscle |
safety and biodistribution: -i.c. serially autologous injections, increasing concentrations subgroup: -efficacy in ischemia/reperfusion |
-mitochondria located in the LV, partly in the arterial sheath and in the right carotid artery, small amount in descending aorta -mitochondria within cardiomyocytes, interstitial spaces and the vascular walls - enhanced regional and global LV function; CBF ↑ in higher concentrations; CBF↑ i.c., no increase after injection -Improved myocardial function (FS↑, proportion LV fractional area change, EF ↑), IS↓ |
-devitalized mitochondria + mitochondria from HeLa- and HeLa-p0 cells | -HeLa mitochondria: CBF ↑ CBF ↑ after i.c. injection of ATP but shorter duration |
|||
Weixler 2020 [133] | in vitro |
-autologous -heart muscle, soleus muscle, gastrocnemius muscle |
-internalization -neonatal rat RV cardiomyocytes |
-no differences in ATP content or mitochondrial internalization |
in vivo: pigs |
-autologous -gastrocnemius muscle |
-injection into RV free wall after pulmonary artery banding |
-TAPSE ↑, contractile function↑, apoptosis ↓, myocardial fibrosis↓ |
|
Cowan 2016 [123] | rabbits | -human adult cardiac fibroblasts | -imaging -Langendorff hearts -global and regional Ischemia/reperfusion -i.c. or local injection |
-most of mitochondria remained within heart throughout reperfusion -majority within interstitial spaces between cardiomyocytes, partly co localization with cardiomyocytes |
-autologous -liver mitochondria |
function: -no ischemia or regional ischemia/reperfusion -antegrade i.c. |
myocardial function ↑ (EDP↓, IS ↓, SS ↑ and dP/dt ↑) |